Company Update (NYSE:COV): Medtronic Acquisition of Covidien Receives U.S. FTC Clearance

[Thomson Reuters ONE] – MINNEAPOLIS AND DUBLIN, Ireland – Nov. 26, 2014 – Medtronic, Inc. (NYSE: MDT) and Covidien plc (NYSE: COV) today announced the receipt of U.S. Federal Trade Commission (FTC) clearance . . . → Read More: Company Update (NYSE:COV): Medtronic Acquisition of Covidien Receives U.S. FTC Clearance Similar Articles: Company Update (NYSE:COV): Covidien’s Fortrex™ PTA Balloon Receives FDA 510(k) Clearance Company Update: Covidien plc (NYSE:COV) – Covidien Reports Fourth-Quarter and Fiscal 2014 Results Stock Update (NYSE:COV): Covidien’s HawkOne™ Directional Atherectomy System Receives FDA 510(K) Clearance for the Treatment of Peripheral Arterial Disease